These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Bentley AM, Meng Q, Robinson DS, Hamid Q, Kay AB, Durham SR. Am J Respir Cell Mol Biol; 1993 Jan; 8(1):35-42. PubMed ID: 8417755 [Abstract] [Full Text] [Related]
25. Intravenous anti-IL-5 monoclonal antibody reduces eosinophils and tenascin deposition in allergen-challenged human atopic skin. Phipps S, Flood-Page P, Menzies-Gow A, Ong YE, Kay AB. J Invest Dermatol; 2004 Jun; 122(6):1406-12. PubMed ID: 15175031 [Abstract] [Full Text] [Related]
31. Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis. Kägi MK, Joller-Jemelka H, Wüthrich B. Dermatology; 1992 Jul; 185(2):88-92. PubMed ID: 1421636 [Abstract] [Full Text] [Related]
33. Human eosinophils constitutively express a functional interleukin-4 receptor: interleukin-4 -induced priming of chemotactic responses and induction of PI-3 kinase activity. Dubois GR, Schweizer RC, Versluis C, Bruijnzeel-Koomen CA, Bruijnzeel PL. Am J Respir Cell Mol Biol; 1998 Oct; 19(4):691-9. PubMed ID: 9761767 [Abstract] [Full Text] [Related]
34. Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. Dubucquoi S, Desreumaux P, Janin A, Klein O, Goldman M, Tavernier J, Capron A, Capron M. J Exp Med; 1994 Feb 01; 179(2):703-8. PubMed ID: 8294877 [Abstract] [Full Text] [Related]
35. [The role of eosinophilic granulocytes for the pathogenesis of atopic dermatitis /neurodermatitis. Eosinophilic products as markers of disease activity]. Kapp A. Hautarzt; 1993 Jul 01; 44(7):432-6. PubMed ID: 8365876 [Abstract] [Full Text] [Related]
36. Eosinophilic cationic protein (ECP) in skin disorders. Juhlin L, Venge P. Acta Derm Venereol; 1991 Jul 01; 71(6):495-501. PubMed ID: 1685831 [Abstract] [Full Text] [Related]
37. Evidence for expression of eosinophil-associated IL-12 messenger RNA and immunoreactivity in bronchial asthma. Nutku E, Gounni AS, Olivenstein R, Hamid Q. J Allergy Clin Immunol; 2000 Aug 01; 106(2):288-92. PubMed ID: 10932072 [Abstract] [Full Text] [Related]
38. Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis. Mashiko S, Bouguermouh S, Rubio M, Baba N, Bissonnette R, Sarfati M. J Allergy Clin Immunol; 2015 Aug 01; 136(2):351-9.e1. PubMed ID: 25792465 [Abstract] [Full Text] [Related]
39. Membrane-bound and soluble alpha IL-5 receptor mRNA in the bronchial mucosa of atopic and nonatopic asthmatics. Yasruel Z, Humbert M, Kotsimbos TC, Ploysongsang Y, Minshall E, Durham SR, Pfister R, Menz G, Tavernier J, Kay AB, Hamid Q. Am J Respir Crit Care Med; 1997 Apr 01; 155(4):1413-8. PubMed ID: 9105087 [Abstract] [Full Text] [Related]
40. Tacrolimus decreases the expression of eotaxin, CCR3, RANTES and interleukin-5 in atopic dermatitis. Park CW, Lee BH, Han HJ, Lee CH, Ahn HK. Br J Dermatol; 2005 Jun 01; 152(6):1173-81. PubMed ID: 15948978 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]